Bicalutamide Tablet
Product Images NDC 51407-010

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Bicalutamide (NDC 51407-010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-010-30 (pl) .jpg (51407 010 30 (pl))

This product is a tablet containing Bicalutamide USP. The dosage information can be found in the accompanying prescribing information. The warning advises to keep the medication away from children. It should be stored at a controlled room temperature between 20° to 25°C (65° to 77°F). The tablets are manufactured by Corden Pharma GmbH in Plankstadt, Germany, and marketed by GSMS, Incorporated in Camarillo, CA, USA. The package contains 30 tablets.*

FDA Label Image

Ani (Ani)

FDA Label Image

Chem (Image 01)

FDA Label Image

Figure-1 (Image 02)

The text provides information on the proportion surviving for Flutamide plus LHRH-A treatment over a span of 4 years. It shows the number of days to death, with data points at 365, 730, 1095, 1460, and 1825 days.*

FDA Label Image

Figure-2 (Image 03)

This is statistical data comparing the progression rates of two different treatments for a medical condition. One treatment involves the combination of Bicalutamide and LHRH-A, while the other involves Flutamide and LHRH-A. The data shows the number of days it takes for progression to occur under each treatment regimen.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.